VistaGen Therapeutics, Inc. Financial Ratios — VTGN Stock

Profitability (USD)

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
As of date	03/31/2012	03/31/2013	03/31/2014	03/31/2015	03/31/2016	03/31/2017	03/31/2018	03/31/2019	03/31/2020	03/31/2021	03/31/2022	03/31/2023	03/31/2024	03/31/2025	03/31/2026

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	-408.71	-367.99	- -	- -	-62.17	-154.3	-46.47	-55.68	-131.59
Return on Assets (%)	-7,102.68	-2,107.22	-518.29	-5,206.52	-7,498.29	-436.22	-191.4	-194.46	-210.01	-31.45	-52.22	-123.78	-40.57	-49.44	-104.86
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	100	100	- -	- -	- -	100	- -	- -	- -	100	100	100	100	100	100
EBITDA Margin (%)	-622.62	-3,372.9	- -	- -	- -	-781.34	- -	- -	- -	-1,602.26	-4,223.63	25,874.89	-3,050.09	-11,386.42	-5,625.93
Operating Margin (%)	-626.02	-3,389.77	- -	- -	- -	-785.74	- -	- -	- -	-1,646.09	-4,287.75	26,109.25	-3,103.48	-11,517.08	-5,683.69
Incremental Operating Margin (%)	- -	- -	-982.78	- -	- -	- -	326.78	- -	- -	- -	- -	877.39	- -	- -	- -
Pretax Margin (%)	-909.54	-6,428.64	- -	- -	- -	-820.25	- -	- -	- -	-1,645.86	-4,306.88	26,097.8	-2,759.21	-10,578.4	-5,490.78
Profit Margin (%)	-909.66	-6,430.49	- -	- -	- -	-820.44	- -	- -	- -	-1,646.09	-4,307.19	26,100.44	-2,759.59	-10,579.84	-5,491.33
Net Income to Common Margin (%)	-909.66	-11,516.92	- -	- -	- -	-929.89	- -	- -	- -	-3,884.33	-4,392.42	26,100.44	-2,759.59	-10,579.84	-5,491.33
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	44.16	- -	- -	8.17	11.77	6.7	4.43	5.73	57.62	1.94	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	-381.32	-351.69	- -	- -	-60.96	-154.3	-46.47	-55.68	-131.59

Credit (USD)

Credit Ratios API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
As of date	03/31/2012	03/31/2013	03/31/2014	03/31/2015	03/31/2016	03/31/2017	03/31/2018	03/31/2019	03/31/2020	03/31/2021	03/31/2022	03/31/2023	03/31/2024	03/31/2025	03/31/2026

Total Debt	4	5	7	14	- -	- -	- -	- -	4	4	3	3	2	2	1
ST Debt	1	1	2	14	- -	- -	- -	- -	- -	- -	- -	1	1	1	1
LT Debt	3	5	5	- -	- -	- -	- -	- -	4	3	3	2	2	1	- -
Total Debt/EBITDA	-0.43	-0.79	-1.45	-2.12	-0.01	-0.01	- -	- -	-0.21	-0.21	-0.06	-0.05	-0.07	-0.03	-0.01
Net Debt/EBITDA	-0.41	-0.69	-1.45	-2.11	0.03	0.29	0.75	0.53	0.07	5.91	1.45	0.28	3.67	1.21	0.43
Total Debt/EBIT	-0.42	-0.79	-1.43	-2.1	-0.01	-0.01	- -	- -	-0.2	-0.21	-0.06	-0.05	-0.06	-0.03	-0.01
Net Debt/EBIT	-0.41	-0.69	-1.43	-2.09	0.03	0.29	0.74	0.53	0.07	5.75	1.43	0.28	3.61	1.2	0.43
EBITDA to Interest Expense	-4.41	-6.73	-3.05	-1.46	-15.08	-1,953.36	- -	-3,054.91	-1,324.74	-1,342.82	- -	-2,553.74	- -	- -	- -
EBITDA-CapEx/Interest Expense	-4.43	-6.87	-3.06	-1.46	-15.11	-2,001.18	- -	-3,076.66	-1,324.74	-1,364	- -	-2,562.96	- -	- -	- -
EBIT to Interest Expense	-4.44	-6.77	-3.09	-1.47	-15.14	-1,964.34	- -	-3,066.31	-1,331.61	-1,379.55	- -	-2,576.87	- -	- -	- -
Interest Expense	2	1	2	5	1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-1,670.37	-1,424.49	-4,854.15	-7,617.09	-301.44	16.48	61.29	50.47	-99.33	84.94	86.7	57.28	92.42	83.46	73.14
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	1.93	0.13	0.09	- -	3.64	4.03	17.55	1.37	1.35	0.7
Long-Term Debt/Capital (%)	-131.4	-64.22	-81.4	-5.3	-0.94	1.74	0.13	0.09	-227.08	3.5	3.85	14.33	1.35	1.32	0.68
Long-Term Debt/Total Assets (%)	821.93	525.2	1,815.17	123.43	2.75	0.32	0.08	0.04	64.42	3.09	3.49	10.05	1.27	1.12	0.51
Total Debt/Equity (%)	-62.55	-42.59	-54.06	-69.43	-2.42	11.22	0.95	0.94	-71.42	4.04	4.7	22.44	1.85	2.14	2.94
Total Debt/Capital (%)	-167.03	-74.18	-117.66	-227.15	-2.47	10.09	0.94	0.93	-249.87	3.89	4.48	18.33	1.82	2.1	2.86
Total Debt/Total Assets (%)	1,044.76	606.63	2,623.89	5,288.62	7.26	1.86	0.58	0.48	70.89	3.43	4.07	12.86	1.71	1.79	2.15
Net Debt to Equity	-60.78	-37.4	-54.01	-69.08	12.01	-465.49	-149.27	-184.35	22.67	-112.1	-105.28	-136.86	-104.27	-95.37	-86.41
Net Debt/Capital (%)	-156.36	-59.84	-117.56	-223.51	10.73	128.17	304.03	218.9	43.39	1,391.25	17,869.21	895.13	4,317.61	-1,407.95	-531.48
EBITDA	-8	-7	-5	-7	-12	-10	-14	-24	-20	-17	-47	-59	-32	-55	-71
EBITDA-CapEx	-8	-7	-5	-7	-12	-10	-14	-25	-20	-18	-47	-59	-33	-56	-72
Operating Income (Loss)	-8	-7	-5	-7	-12	-10	-14	-25	-20	-18	-48	-59	-33	-56	-72

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
As of date	03/31/2012	03/31/2013	03/31/2014	03/31/2015	03/31/2016	03/31/2017	03/31/2018	03/31/2019	03/31/2020	03/31/2021	03/31/2022	03/31/2023	03/31/2024	03/31/2025	03/31/2026

Cash Ratio	0.03	0.26	- -	- -	0.24	2.14	7.12	4.68	0.49	24.61	11.82	3.64	23.26	6.38	3.55
Current Ratio	0.07	0.28	0.01	0.01	0.48	2.47	7.56	4.87	0.57	24.85	12.32	3.83	23.55	6.51	3.67
Quick Ratio	0.06	0.26	- -	- -	0.24	2.14	7.12	4.78	0.49	24.62	12.29	3.81	23.26	6.38	3.55
CFO/Avg Current Liab	-2.24	-1.24	-0.56	-0.25	-0.5	-4.59	-6.41	-6.82	-5.66	-3.47	-9.09	-9.62	-5.32	-4.75	-5.23
Common Equity/Total Assets	-1,670.37	-1,424.49	-4,854.15	-7,617.09	-301.44	16.48	61.29	50.47	-99.33	84.94	86.7	57.28	92.42	83.46	73.14
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	1.93	0.13	0.09	- -	3.64	4.03	17.55	1.37	1.35	0.7
Long-Term Debt/Capital (%)	-131.4	-64.22	-81.4	-5.3	-0.94	1.74	0.13	0.09	-227.08	3.5	3.85	14.33	1.35	1.32	0.68
Long-Term Debt/Total Assets (%)	821.93	525.2	1,815.17	123.43	2.75	0.32	0.08	0.04	64.42	3.09	3.49	10.05	1.27	1.12	0.51
Total Debt/Equity (%)	-62.55	-42.59	-54.06	-69.43	-2.42	11.22	0.95	0.94	-71.42	4.04	4.7	22.44	1.85	2.14	2.94
Total Debt/Capital (%)	-167.03	-74.18	-117.66	-227.15	-2.47	10.09	0.94	0.93	-249.87	3.89	4.48	18.33	1.82	2.1	2.86
Total Debt/Total Assets (%)	1,044.76	606.63	2,623.89	5,288.62	7.26	1.86	0.58	0.48	70.89	3.43	4.07	12.86	1.71	1.79	2.15
CFO/Total Liabilities	-58.97	-25.77	-16.27	-13.3	-121.21	-234.53	-207.68	-209.44	-137	-74.06	-455.84	-551.85	-275.57	-301.75	-509.32
CFO/CapEx	-110.06	-25.58	-221.46	- -	-182.83	-30.37	-5,661.44	-83.49	- -	-43.84	-225.83	-234.51	-423.16	-220.4	-439.97
Altman's Z-Score	-307.59	-26.81	-458.39	-598.13	-223.42	-57.94	-19.55	-18.23	-59.51	11.89	9.42	-28.49	5.36	-4.84	-16.75

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
As of date	03/31/2012	03/31/2013	03/31/2014	03/31/2015	03/31/2016	03/31/2017	03/31/2018	03/31/2019	03/31/2020	03/31/2021	03/31/2022	03/31/2023	03/31/2024	03/31/2025	03/31/2026

Accounts Receivable Turnover

- -

Days Sales Outstanding

- -

Inventory Turnover

- -

Days Inventory Outstanding

- -

Accounts Payable Turnover

- -

Accounts Payable Turnover Days

- -

Cash Conversion Cycle

- -

Inventory to Cash Days

- -

Inventories

- -

Raw Materials

- -

Work In Process

- -

Finished Goods

- -

Other Inventory

- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
As of date	03/31/2012	03/31/2013	03/31/2014	03/31/2015	03/31/2016	03/31/2017	03/31/2018	03/31/2019	03/31/2020	03/31/2021	03/31/2022	03/31/2023	03/31/2024	03/31/2025	03/31/2026

Market Capitalization	46	17	11	15	22	17	21	55	22	385	256	26	143	72	23
- Cash & Cash Equivalents	- -	1	- -	- -	- -	3	10	13	1	103	68	17	119	67	31
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	4	5	7	14	- -	- -	- -	- -	4	4	3	3	2	2	1
Enterprise Value	49	22	18	30	21	14	11	42	24	285	191	12	26	-6	-22
Total Capital	-2	-7	-6	-6	-3	1	7	7	-2	96	68	15	116	72	37
Total Debt/Capital (%)	-167.03	-74.18	-117.66	-227.15	-2.47	10.09	0.94	0.93	-249.87	3.89	4.48	18.33	1.82	2.1	2.86
Total Debt / EV	0.07	0.24	0.39	0.48	- -	- -	0.01	- -	0.17	0.01	0.02	0.22	0.08	-0.23	-0.05
EV/Sales	36.53	109.51	- -	- -	- -	11.58	- -	- -	- -	261.89	172.26	- -	24.1	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	16.01	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	16.01	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	40	15	10	13	15	15	13	37	19	183	246	25	102	77	22
Diluted Enterprise Value	44	20	17	27	15	12	3	24	22	84	180	11	-15	12	-8
EV per Share	1,769.93	634.08	452.78	576.25	258.28	49.13	14.41	29.23	14.87	47.39	27.74	1.7	0.95	- -	- -
TTM Sales	1	- -	- -	- -	- -	1	- -	- -	- -	1	1	- -	1	- -	1
TTM EBITDA	-8	-7	-5	-7	-12	-10	-14	-24	-20	-17	-47	-59	-32	-55	-71
TTM Operating Income	-8	-7	-5	-7	-12	-10	-14	-25	-20	-18	-48	-59	-33	-56	-72
TTM Cash Flow to Firm	-2	-2	-1	2	-4	-7	-9	-15	-16	-12	-45	-50	-26	-42	-66
TTM Free Cash Flow to Firm	-2	-2	-1	2	-4	-7	-9	-14	-16	-12	-45	-49	-26	-42	-66

Multiples (USD)

Valuation Multiples API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
As of date	03/31/2012	03/31/2013	03/31/2014	03/31/2015	03/31/2016	03/31/2017	03/31/2018	03/31/2019	03/31/2020	03/31/2021	03/31/2022	03/31/2023	03/31/2024	03/31/2025	03/31/2026

Price/Free Cash Flow	-11.43	-4.52	-4.78	-4.76	-3.23	-2.1	-1.43	-2.55	-1.23	-15.55	-5.45	-0.51	-3.97	-1.84	-0.33
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	49	22	18	30	21	14	11	42	24	285	191	12	26	-6	-22
Low Price	1,050	36	150	94.8	120	52.2	20.7	24.3	8.7	10.5	31.8	2.4	1.62	2.22	0.43
EV/Sales	36.53	109.51	- -	- -	- -	11.58	- -	- -	- -	261.89	172.26	- -	24.1	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	-3.29	-0.8	-4.19	-0.99	-0.31	-2.57	-1.37	-1.6	-1.54	-2.13	-9.16	-1.59	-2.72	-2.01	-1.31
Price/Earnings High	-3.8	-2.2	-6.66	-1.42	-0.57	-5.83	-2.39	-2.71	-2.97	-6.47	-14.43	-6.31	-16.29	-3.45	-2.81
Price/Earnings Low	-2.11	-0.05	-1.85	-0.3	-0.14	-1.13	-0.62	-0.9	-0.58	-0.71	-4.31	-0.28	-1.07	-1.33	-0.23
Price/Book Value	-7.98	-1.37	-0.84	-0.75	-7.29	28.32	3.09	7.72	-3.78	4.18	3.96	2.18	1.25	1.03	0.64
Price/Book Value Average	-7.95	-1.69	-1.04	-0.78	-7.6	57.32	5.02	8.7	-6.62	2.05	7.19	8.17	0.98	1.38	2.67
Price/Book Value High	-9.18	-4.63	-1.65	-1.13	-13.76	130.02	8.79	14.71	-12.79	6.24	11.33	32.5	5.84	2.36	5.73
Price/Book Value Low	-5.1	-0.1	-0.46	-0.24	-3.33	25.14	2.29	4.88	-2.49	0.69	3.38	1.45	0.38	0.91	0.48
Price/Tangible Book Value	-7.98	-1.37	-0.84	-0.75	-7.29	28.32	3.09	7.72	-3.78	4.18	3.96	2.18	1.25	1.03	0.64
Price/Tangible Book Value Average	-7.95	-1.69	-1.04	-0.78	-7.6	57.32	5.02	8.7	-6.62	2.05	7.19	8.17	0.98	1.38	2.67
Price/Tangible Book Value High	-9.18	-4.63	-1.65	-1.13	-13.76	130.02	8.79	14.71	-12.79	6.24	11.33	32.5	5.84	2.36	5.73
Price/Tangible Book Value Low	-5.1	-0.1	-0.46	-0.24	-3.33	25.14	2.29	4.88	-2.49	0.69	3.38	1.45	0.38	0.91	0.48
Price/Sales	30.08	75	- -	- -	- -	11.81	- -	- -	- -	168.39	221.41	-110.37	96.04	158.83	17.15
Price/Sales Average	29.96	92.4	- -	- -	- -	23.91	- -	- -	- -	82.55	402.22	-413.81	75.1	212.9	71.76
Price/Sales High	34.59	253.01	- -	- -	- -	54.23	- -	- -	- -	251.4	633.87	-1,646.35	449.48	364.68	154.22
Price/Sales Low	19.21	5.42	- -	- -	- -	10.48	- -	- -	- -	27.67	189.27	-73.58	29.47	141.04	12.9
Price/Cash Flow	-11.32	-4.34	-4.75	-4.76	-3.22	-2.03	-1.43	-2.52	-1.23	-15.2	-5.43	-0.5	-3.96	-1.83	-0.33
Price/Cash Flow Average	-11.28	-5.35	-5.85	-4.94	-3.35	-4.11	-2.32	-2.84	-2.15	-7.45	-9.86	-1.89	-3.1	-2.46	-1.37
Price/Cash Flow High	-13.02	-14.64	-9.3	-7.14	-6.07	-9.33	-4.06	-4.8	-4.15	-22.69	-15.53	-7.52	-18.53	-4.21	-2.95
Price/Cash Flow Low	-7.23	-0.31	-2.58	-1.51	-1.47	-1.8	-1.06	-1.59	-0.81	-2.5	-4.64	-0.34	-1.21	-1.63	-0.25
Price/Free Cash Flow Average	-11.38	-5.56	-5.88	-4.94	-3.37	-4.26	-2.32	-2.87	-2.15	-7.62	-9.9	-1.9	-3.1	-2.47	-1.37
Price/Free Cash Flow High	-13.14	-15.24	-9.35	-7.14	-6.1	-9.65	-4.06	-4.86	-4.15	-23.22	-15.6	-7.55	-18.57	-4.23	-2.95
Price/Free Cash Flow Low	-7.3	-0.33	-2.6	-1.51	-1.48	-1.87	-1.06	-1.61	-0.81	-2.56	-4.66	-0.34	-1.22	-1.64	-0.25
EV/Sales Average	36.39	129.46	- -	- -	- -	25.78	- -	- -	- -	81.89	360.87	- -	- -	64.91	51.23
EV/Sales High	41.6	313.65	- -	- -	- -	61.36	- -	- -	- -	435.95	602.51	- -	517.62	207.45	137.04
EV/Sales Low	24.27	29.72	- -	- -	- -	10.02	- -	- -	- -	- -	138.73	- -	- -	6.02	- -
EV/EBITDA Average	-5.84	-3.84	-4.24	-4.49	-1.91	-3.3	-1.77	-1.98	-2.05	-5.11	-8.54	-1.44	0.17	-0.57	-0.91
EV/EBITDA High	-6.68	-9.3	-5.88	-5.55	-3.47	-7.85	-3.65	-3.72	-3.83	-27.21	-14.27	-6.45	-16.97	-1.82	-2.44
EV/EBITDA Low	-3.9	-0.88	-2.68	-2.84	-0.82	-1.28	-0.4	-0.88	-0.86	2.07	-3.28	-0.06	2.26	0.02	0.18
EV/EBIT Average	-5.81	-3.82	-4.19	-4.45	-1.9	-3.28	-1.75	-1.98	-2.04	-4.97	-8.42	-1.43	0.17	-0.56	-0.9
EV/EBIT High	-6.65	-9.25	-5.82	-5.51	-3.46	-7.81	-3.63	-3.71	-3.81	-26.48	-14.05	-6.39	-16.68	-1.8	-2.41
EV/EBIT Low	-3.88	-0.88	-2.65	-2.81	-0.82	-1.28	-0.4	-0.88	-0.85	2.02	-3.24	-0.06	2.22	0.02	0.18
Last Price	1,644	498	276	300	262.5	58.8	27.9	38.4	13.2	63.9	37.2	3.6	5.28	2.5	0.57
High Price	1,890	1,680	540	450	495	270	79.5	73.2	44.7	95.4	106.5	53.7	24.71	5.74	5.14
Enterprise Value Average	49	26	20	30	22	32	24	48	41	89	400	85	-5	32	65
Enterprise Value High	56	63	28	37	41	77	50	91	76	475	668	379	551	101	174
Enterprise Value Low	33	6	13	19	10	13	6	21	17	-36	154	4	-73	-1	-13

Shares Outstanding	- -	- -	- -	- -	- -	- -	1	1	2	6	7	7	27	29	40
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	1	1	3	7	7	19	31	38
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	1	1	3	7	7	19	31	38
Revenue per Share	54.65	6.64	- -	- -	- -	4.98	- -	- -	- -	0.38	0.17	-0.03	0.05	0.02	0.03
EBITDA per Share	-340.25	-223.97	-130.22	-152.82	-198.78	-38.9	-29.86	-25.67	-13.59	-6.08	-7.1	-8.44	-1.68	-1.79	-1.88
Operating Income per Share	-342.1	-225.09	-131.71	-154.17	-199.68	-39.12	-30.04	-25.77	-13.66	-6.25	-7.2	-8.52	-1.71	-1.81	-1.89
Basic EPS, GAAP	-497.11	-764.74	-81.03	-315.87	-872.53	-46.3	-33.21	-27.02	-15.07	-14.74	-7.38	-8.51	-1.52	-1.67	-1.83
Basic EPS from Cont Ops	-497.11	-426.99	-81.03	-315.87	-801.28	-40.85	-30.98	-25.83	-14.21	-6.25	-7.24	-8.51	-1.52	-1.67	-1.83
Diluted EPS, GAAP	-497.11	-764.74	-81	-315.87	-872.53	-46.3	-33.21	-27.02	-15.07	-14.74	-7.38	-8.51	-1.52	-1.67	-1.83
Diluted EPS from Cont Ops	-497.11	-426.99	-81	-315.87	-801.28	-40.85	-30.98	-25.83	-14.21	-6.25	-7.24	-8.51	-1.52	-1.67	-1.83
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-145.18	-114.75	-58.05	-62.99	-81.6	-28.93	-19.56	-15.26	-10.78	-4.21	-6.86	-7.14	-1.33	-1.36	-1.74
Free Cash Flow per Basic Share	-146.5	-119.24	-58.31	-62.99	-82.04	-29.88	-19.57	-15.44	-10.78	-4.3	-6.89	-7.17	-1.34	-1.37	-1.75
Cash & Equivalents per Share	2.92	18.44	- -	1.36	5.17	9.92	13.58	9.22	0.83	17.13	9.9	2.28	4.41	2.78	1.15
Book Value per Share	-205.99	-362.8	-327.01	-399.82	-35.99	2.08	9.04	4.98	-3.5	15.28	9.4	1.65	4.23	2.43	0.9
Tangible Book Value per Share	-205.99	-362.8	-327.01	-399.82	-35.99	2.08	9.04	4.98	-3.5	15.28	9.4	1.65	4.23	2.43	0.9

VistaGen Therapeutics, Inc.